BM 15766 sulfate, > = 98% ( HPLC), poudre

Code: b8685-5mg D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

Dehydrocholesterol reductase inhibitor. Inhibits 7-dehydrocholesterol reductase, which catalyzes the last step of cholesterol synthesis.

AJOUTER

Votre prix

£728.00 5MG

DEMANDER

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

Dehydrocholesterol reductase inhibitor. Inhibits 7-dehydrocholesterol reductase, which catalyzes the last step of cholesterol synthesis.

Features and Benefits

This compound was developed by Roche. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Packaging

1, 5 mg in glass bottle

assay	≥98% (HPLC)
color	white
form	powder
InChI key	OVMQIVIYKXXEIT-UHFFFAOYSA-N
InChI	1S/C22H25ClN2O2.H2O4S/c23-21-9-5-18(6-10-21)2-1-12-24-14-16-25(17-15-24)13-11-19-3-7-20(8-4-19)22(26)27;1-5(2,3)4/h1-10H,11-17H2,(H,26,27);(H2,1,2,3,4)
mp	>300 °C
originator	Roche
Quality Level	100
SMILES string	OS(O)(=O)=O.OC(=O)c1ccc(CCN2CCN(CC2)CC=Cc3ccc(Cl)cc3)cc1
solubility	water: insoluble, DMSO: soluble 4 mg/mL
storage temp.	2-8°C

Code

Description

Unité de vente

Prix annoncé

Qté

B8685-1MG

Unité:1MG

Prix annoncé: £193.00

Source:Prix annoncé

AJOUTER

Cas Number

86621-94-5

Ce produit répond aux critères suivants:

Partager le panier